CYSTADROPS

This brand name is authorized in Austria, Canada, Estonia, Finland, France, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug CYSTADROPS contains one active pharmaceutical ingredient (API):

1 Mercaptamine UNII IF1B771SVB - CYSTEAMINE HYDROCHLORIDE

Mercaptamine reduces corneal cystine crystal accumulation acting as a cystine-depleting agent by converting cystine to cysteine and cysteine-cysteamine mixed disulfides. Read about Mercaptamine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CYSTADROPS Eye drops solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01XA21		S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02485605
Country: EE	Ravimiamet	Identifier(s): 1737064
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 382318, 564033
Country: FR	Base de données publique des médicaments	Identifier(s): 65839815
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 345926
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8501
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1082007, 1091272
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 149845
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100387792
Country: US	FDA, National Drug Code	Identifier(s): 55292-410